⏲️ 3 mins read Diagnosis Juliana, from Brazil, was diagnosed with Limb-girdle muscular dystrophy type 2B when she just turned 25 years old. The first symptoms were weakness in her lower limbs, lack of balance resulting in constant falls and difficulty in climbing stairs. As the years progressed her limitations worsened … read more
Ischemic stroke is the most common form of stroke, caused by a narrowing or blockage of blood flow in the brain. As a result of this lack of blood flow, cells begin to die and this can cause irreparable damage. When Ana had an ischemic stroke a few years ago, … read more
⏲️ 3 mins read Saif, a 15-year-old boy from the United States is back for his 6th treatment with Beike Biotech. His mom, kindly accepted to respond to a Q&A session about our stem cell treatment. We chose Beike after detailed research and it was one of the best decisions we’ve made. Tell … read more
Stem Cell Therapy for PLS Since being diagnosed with primary lateral sclerosis (PLS) in February of 2016, Sylvie has taken three trips to Thailand to receive stem cell treatment, finishing her most recent treatment in October of 2018. Before receiving stem cell therapy for PLS, her symptoms included spasticity in her arms … read more
Study shows cell therapy could repair brain injury A mice study has found that cord blood stem cells, stem cells derived from the umbilical cord, can protect nerve cells from injury caused before birth. The results give positive reinforcement to the push for more cell therapies as potential therapeutic alternatives … read more
The European Commission has approved Alofisel, previously known as Cx601, a stem cell therapy that treats complex perianal fistulas, one of the most restricting complications of Crohn’s disease. Alofisel was developed by Belgian biotech company TiGenix, and is licensed to the Japanese pharma Takeda. It is the first stem cell … read more
A study has found that bone marrow transplants can restore nerve cell damage in mice with Friedreich’s ataxia (FA), forming new nerve cells and improving movement. FA is a genetic disorder caused by an FXN gene mutation for frataxin. Frataxin is a protein that allows the mitochondria in cells to … read more
